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We have previously reported that there are inter-individual differences in the
cardiovascular responses to experimental muscle pain, which are consistent over time:
intramuscular infusion of hypertonic saline, causing pain lasting ∼60min, increases
muscle sympathetic nerve activity (MSNA)—as well as blood pressure and heart
rate—in certain subjects, but decrease it in others. Here, we tested the hypothesis that
baseline physiological parameters (resting MSNA, heart rate, blood pressure, heart rate
variability) determine the cardiovascular responses to long-lasting muscle pain. MSNA
was recorded from the common peroneal nerve, together with heart rate and blood
pressure, during a 45-min intramuscular infusion of hypertonic saline solution into the
tibialis anterior of 50 awake human subjects (25 females and 25 males). Twenty-four
subjects showed a sustained increase in mean amplitude of MSNA (160.9 ± 7.3%),
while 26 showed a sustained decrease (55.1 ± 3.5%). Between the increasing and
decreasing groups there were no differences in baseline MSNA (19.0± 1.5 vs. 18.9± 1.2
bursts/min), mean BP (88.1 ± 5.2 vs. 88.0 ± 3.8mmHg), HR (74.7 ± 2.0 vs. 72.8 ± 1.8
beats/min) or heart rate variability (LF/HF 1.8 ± 0.2 vs. 2.2 ± 0.3). Furthermore, neither
sex nor bodymass index had any effect on whether MSNA increased or decreased during
tonic muscle pain. We conclude that the measured baseline physiological parameters
cannot account for the divergent sympathetic responses during tonic muscle pain.
Keywords: blood pressure, HRV, MSNA, muscle pain, muscle sympathetic nerve activity
INTRODUCTION
Pain is important for survival by helping to avoid tissue damage, mobilizing all relevant homeostatic
systems for a fight-and-flight response or, alternatively, promoting conservation of energy, and
thus promoting healing (Craig, 2002). It is well known that pain originating in deep structures
may evoke very different behavioral and cardiovascular responses than pain originating in
superficial structures. Indeed, Lewis (1942) observed that pain originating in skin evokes “a rise
of pulse rate” and a “sense of invigoration” whereas pain originating in deep structures evokes
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quiescence, a “slowing of the pulse” and “falling of the blood
pressure” (Lewis, 1942). Subsequent studies confirmed Lewis’
findings that muscle pain was associated with a fall in blood
pressure and bradycardia in awake human subjects (Feinstein
et al., 1954). However, since these early observations by Lewis and
Feinstein, very few studies have examined the effects of pain on
the cardiovascular system in awake human subjects.
We have been using subcutaneous or intramuscular injection
of hypertonic saline—a specific stimulus for nociceptors
(Graven-Nielsen and Mense, 2001)—to study the effects of acute
pain on the cardiovascular system in awake human subjects. We
showed that a bolus (0.5ml) injection of hypertonic saline into
the tibialis anterior muscle caused a sustained increase in muscle
sympathetic nerve activity (MSNA), and a modest increase in
blood pressure and heart rate (Burton et al., 2009a), while there
was only a transient increase in skin sympathetic nerve activity
(SSNA)—the latter being consistent with an arousal rather than
reflex response (Burton et al., 2009b). More recently, we used
intramuscular infusion to produce a sustained, steady-state, level
of pain lasting for approximately 1 h (Fazalbhoy et al., 2012,
2014). We showed that about half of the subjects showed a
sustained increase in MSNA, blood pressure, and heart rate
during tonic muscle pain, while the other half showed sustained
decreases (Fazalbhoy et al., 2012, 2014).
These data call into question the idea that noxious stimuli
produce invariant responses and raise the prospect that these
differential responses may be related to an individual’s particular
traits, which may be reproducible over time. That is, in some
individuals muscle pain always evokes increases in MSNA, blood
pressure and heart rate, whereas in others it consistently evokes
decreases. Indeed, we recently showed that subjects who generate
increases in MSNA, blood pressure and heart rate during one
session also show increases in a second session; the same is true
for those who show parallel decreases in MSNA, blood pressure
and heart rate (Fazalbhoy et al., 2014). Moreover, we showed that
there were no differences in resting MSNA, blood pressure or
heart rate between the two recording sessions (Fazalbhoy et al.,
2014), but we do not know whether differences in these baseline
physiological parameters across individuals determines whether
MSNA increases or decreases during tonic muscle pain. Indeed,
in our first study we showed that resting levels of MSNA were
higher in the group that showed an increase in MSNA than in
the group that showed a decrease, but these differences failed
to reach statistical significance—presumably because of the low
subject numbers (n = 12) Against this background, the aim of the
current study was to determine whether baseline physiological
parameters—including resting MSNA, blood pressure and heart
rate—could account for the divergent MSNA responses to tonic
muscle pain. Our earlier studies (Fazalbhoy et al., 2012, 2014)
were based on small subject numbers and were not sex-balanced.
Here, we have studied a larger sample (n = 50), comprising 25
males and 25 females.
METHODS
Experiments were performed on 25 female and 25 male healthy
subjects, aged 18–39 years. Data from 35 new participants were
pooled with those from 15 participants reported previously
(Fazalbhoy et al., 2014). All subjects provided informed written
consent to the experimental procedures, which were conducted
under the approval of the Human Research Ethics Committee of
the University of Western Sydney and satisfied the requirements
of the Helsinki Declaration. No subject had a history of
cardiovascular disease or former chronic musculoskeletal pain.
Prior to commencement height, weight, body mass index (BMI),
and total muscle mass were measured for each subject using a
body-composition analyser (SA165A, Tanita, Japan).
Experimental Procedures
The subjects were seated in a comfortable reclined position with
the legs supported in an extended position. The room was kept
quiet and at a constant temperature of 22◦C. The course of the
common peroneal nerve was identified via external stimulation
(2–10mA) using a 1mm surface probe which delivered 0.2ms
pulses at 1Hz from an isolated stimulator (Stimulus Isolator;
ADInstruments, Sydney, Australia). Spontaneous bursts of
muscle sympathetic nerve activity (MSNA) were recorded from
muscle fascicles of the common peroneal nerve supplying
the ankle or toe extensor or foot everter muscles via
tungsten microelectrodes (FHC, Bowdoin, ME, USA) inserted
percutaneously at the level of the fibular head. Multi-unit neural
activity was amplified (gain 20 000, bandpass 0.3–5.0 kHz) using
an isolated amplifier (NeuroAmp EX, ADInstruments, Sydney,
Australia) and stored on computer (10-kHz sampling) using a
computer-based data acquisition and analysis system (PowerLab
16SP hardware and LabChart 7 software; ADInstruments,
Sydney, Australia). ECG (0.3–1.0 kHz) was recorded with
Ag–AgCl surface electrodes on the chest and sampled at
2 kHz. Blood pressure was recorded continuously using finger
pulse plethysmography (Finometer Pro, Finapres Medical
Systems, The Netherlands) and sampled at 400Hz. Respiration
(DC-100Hz) was recorded using a strain-gauge transducer
(Pneumotrace, UFI, Morro Bay CA, USA) wrapped around the
chest.
Noxious Stimulation
A 7% hypertonic saline solution was prepared by diluting sterile,
20% hypertonic saline with sterile water. Two syringes of 10ml
each were filled with the 7% hypertonic saline, placed in an
infusion pump (Harvard Instruments, USA), and connected
to a three-way tap via a 75 cm extension tubing primed with
hypertonic saline. A 23 gauge butterfly needle was then attached
to the three-way tap via a cannula, primed, and inserted 1.5 cm
deep into the belly of the ipsilateral tibialis anterior muscle,
about 5 cm lateral and 10 cm inferior to the tibial tuberosity.
The cannula was inserted as soon as a stable recording of
spontaneous MSNA was achieved. Prior to infusion of the saline
solution, a 5min baseline recording of MSNA, blood pressure,
respiration, and heart rate was obtained. Infusion of the 7%
hypertonic saline solution was started at a time unknown to the
subject, and was maintained for 45min; as described previously
(Fazalbhoy et al., 2012, 2014), the pain lasted for ∼60min.
The initial rate of infusion was set at 0.25ml/min and was
constantly adjusted to maintain a pain level of 5–6/10 on a
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Numerical Rating Scale (NRS). Subjects were asked to rate their
pain continuously by sliding a linear potentiometer (Response
Meter, ADInstruments, Sydney, Australia) that was calibrated
to the NRS, with a rating of “0” meaning “no pain/discomfort”
at all, and a rating of “10” being equivalent to the “worst pain
the subject ever had experienced.” When the pain level dropped
below 4/10 or rose above 6/10, the infusion rate was changed
by 0.02ml/min accordingly. After the infusion was completed,
the recording was continued until the pain stopped. At the
conclusion of the experiment, each subject completed a McGill
Pain Questionnaire, in which subjects described the quality of the
pain using a standard set of descriptors.
Analysis
LabChart 7 Pro software (ADInstruments, Sydney, Australia) was
used to record the following parameters: muscle sympathetic
nerve activity (burst amplitude and frequency), heart rate, blood
pressure, respiration, pulse pressure, heart rate variability (HRV),
and pain ratings. Individual bursts of MSNA were displayed as
a mean-voltage neurogram, computed as the root-mean-square
(RMS) processed signal with a moving time average window of
200ms. This signal was then analyzed using the “Peak Analysis”
module of the LabChart 7 Pro software to calculate the amplitude
of each burst. The absolute values were averaged into 5-min
blocks and reported as percentages from the “baseline” values.
An average of all blocks was taken to determine the direction of
the response. Subjects with overall averageMSNA amplitude 10%
lower than baseline were arbitrarily assigned to the decreasing
group; averages 10% higher than baseline were considered as
increasing. Baseline MSNA amplitude was compared to the 5-
min block with the mean value calculated over the entire infusion
period, and to the highest average for the increasing group and
to the lowest average value for the decreasing group. Changes in
mean heart rate and mean blood pressure were also measured
in 5min epochs, normalized to the baseline value prior to the
infusion of hypertonic saline. HRV was assessed over a 5-min
steady state period before the infusion, and then again over 5min
when the subject experienced a steady-state level of pain during
the infusion. The parameters of HRV that were analyzed included
the low frequency (LF) and high frequency (HF) power, as well as
the Root Mean Square Successive Difference of cardiac intervals
(RMSSD). Statistical analysis—non-paired two-tailed t-tests for
normally distributed data and Mann-Whitney tests for non-
normally distributed data—was performed using Prism version 6
for Mac OS X (GraphPad software, San Diego, California, USA).
All values are expressed as means and standard error. Probability
levels of p < 0.05 were deemed significant.
RESULTS
Subjective Experience of Tonic Muscle
Pain
In all subjects intramuscular infusion of hypertonic saline
induced a steady state level of muscle pain in the tibialis anterior
muscle. The level of pain was kept constant, typically around 5
out of 10—throughout the period of infusion by adjusting the
rate of infusion according to the subject’s tracking of the pain
level. The mean pain rating was 4.9 ± 0.1. Using the McGill Pain
Questionnaire, 36 of the 50 subjects (72%) described the pain as
“aching,” 48% described it as “heavy” and 48% as “dull.” After
these, “throbbing,” “cramping,” “hurting,” “discomforting,” and
“continuous” were the most frequent descriptions used.
Muscle Sympathetic Nerve Activity During
Tonic Muscle Pain
Experimental records from two subjects are shown in Figures 1,
2. Muscle sympathetic nerve activity (MSNA) increased during
tonic pain in the subject depicted in Figure 1; it is apparent that
blood pressure also increased. Conversely, the subject illustrated
in Figure 2 exhibited a sustained decrease in MSNA and blood
pressure during the infusion.
As expected, when all subjects were analyzed according to
their pattern of MSNA response to muscle pain two distinct
groups of responses emerged: 24 subjects (48%) showed a
significant increase in burst amplitude over the entire infusion
period (132.6 ± 6.1% p < 0.0001, t-test), while 26 subjects
(52%) showed a significant decrease (72.6 ± 3.0%, p < 0.0001,
t-test), relative to baseline. The peak changes in the increasing
and decreasing groups, measured over 5min, were 160.9 ± 7.3%
and 55.1 ± 3.5% respectively; these were significantly different
from baseline (p < 0.0001, t-test). The time at which the peak
increase inMSNA occurred (29± 3min) in the increasing group,
and the time at which the peak fall occurred (32 ± 3min) in the
decreasing group, were not significantly different (p = 0.5077,
Mann-Whitney test). There was no significant difference in the
mean pain rating in the increasing and decreasing groups (4.7 ±
0.2 vs. 5.1± 0.2, respectively; p = 0.18, t-test).
Blood Pressure and Heart Rate During
Tonic Muscle Pain
Interestingly, those subjects who showed an increase in MSNA
showed a significantly larger increase in blood pressure than
those in whom MSNA decreased. Systolic pressure increased
from 132.0 ± 5.5 (baseline) to 159.9 ± 5.8mmHg (steady level
of pain) in the increasing group but from only 133.0 ± 4.7 to
142.7± 5.3 in the decreasing group. Diastolic pressure increased
from 70.2 ± 5.2 (baseline) to 86.6 ± 4.5mmHg (steady level
of pain) and from 75.1 ± 4.2 to 76.7 ± 4.3 in the increasing
and decreasing groups, respectively. Relative changes in blood
pressure, heart rate and MSNA in the two groups are presented
in Figure 3. In the increasing group, data from two subjects were
excluded from the calculated mean of all parameters as they
showed much larger increases in amplitude of MSNA (396 and
520%), as defined by running an Outliers Test (Prism, GraphPad
software), which would have skewed the results.
Resting Levels of MSNA and BP
When comparing the increasing and decreasing groups, there
were no differences in baseline MSNA (19.0 ± 1.5 vs. 18.9 ±
1.2 bursts/min; p = 0.99, t-test) that could account for these
divergent responses. Moreover, as shown in Table 1, there were
no differences in resting blood pressure parameters, heart rate or
heart rate variability, and no effect of body mass index or total
muscle mass.
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FIGURE 1 | Experimental records from one subject in whom MSNA increased during intramuscular infusion of hypertonic saline. Baseline is shown in
the left panel (A), while the right panel (B) shows a sample at which MSNA was at its maximum.
FIGURE 2 | Experimental records from one subject in whom MSNA decreased during intramuscular infusion of hypertonic saline. Baseline is shown in
the left panel (A), while the right panel (B) shows a sample at which MSNA was at its maximum.
Sex Differences
Of the 24 subjects in whom MSNA increased, 11 were female
and 13 were male, while there were 14 females and 12 males
in whom MSNA decreased. These data indicate that there was
no difference in the propensity of males or females to exhibit an
increase or decrease in MSNA during long-lasting muscle pain
(p = 0.78, Fisher’s Exact test). Moreover, the data illustrated
in Figure 4 show that there were no differences in the peak
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FIGURE 3 | Changes in systolic (A) and diastolic (B) pressure, heart
rate (C) and muscle sympathetic nerve activity (MSNA; D) in the group
of subjects in whom MSNA amplitude increased during tonic muscle
pain and the group in whom MSNA amplitude decreased, measured
from the peak changes. Systolic and diastolic pressures were significantly
higher in the increasing group as depicted by the asterisk. Results are
compared to baseline levels (i.e., 100%).
magnitude of change in MSNA between females and males in
either the increasing group (158.0 ± 11.3% vs. 163.2 ± 10.0%;
p = 0.40, Mann-Whitney) or the decreasing group (44.1 ±
4.7% vs. 46.4 ± 5.4%; p = 0.77, Mann-Whitney). There was no
significant difference in the mean pain rating between females
and males (4.9± 0.2 vs. 4.9± 0.2, respectively; p = 0.87, t-test).
There were no statistically significant differences in resting
MSNA between the female and male subjects (18.8 ± 1.5
TABLE 1 | Baseline data for the group showing an increase in MSNA
(n = 24) during tonic muscle pain and the group showing a decrease
(n = 26).
Increasing MSNA Decreasing MSNA P-value
Number of subjects 11 female, 13 male 14 female, 12 male 0.78
Age (years) 22.1±1.3 22.4± 0.9 0.34
Height (cm) 168.7±1.6 170.1± 2.1 0.60
Weight (kg) 65.7±2.6 68.0± 2.9 0.56
BMI (kg/m2) 23.1±1.0 23.4± 0.8 0.65
Muscle mass (kg) 49.5±2.2 48.7± 2.3 0.80
Pain rating (/10) 4.7±0.2 5.1± 0.2 0.18
MSNA (bursts/min) 19.0±1.5 18.9± 1.2 0.99
SAP (mmHg) 132.0±5.5 133.0± 4.7 0.52
DAP (mmHg) 70.2±5.2 75.1± 4.2 0.32
MAP (mmHg) 88.1±5.2 88.0± 3.8 0.78
HR (beats/min) 74.7±2.0 72.8± 1.8 0.44
LF HRV (nu) 56.9±3.8 59.4± 4.0 0.80
HF HRV (nu) 38.4±3.4 35.6± 3.7 0.58
LF/HF HRV 1.8±0.2 2.2± 0.3 0.38
RMSSD HRV (ms) 40.5±4.1 40.8± 4.0 0.99
There were no statistically significant differences in age, height, body-mass index (BMI),
total muscle mass between the two groups, or in baseline levels of MSNA, systolic arterial
pressure (SAP), diastolic arterial pressure (DAP), mean arterial pressure (MAP), heart rate
(HR) and specific components of heart rate variability (HRV; see Methods). Non-paired
tests for all parameters except “number of subjects” (Fisher’s exact test); nu, normalized
units.
FIGURE 4 | Changes in muscle sympathetic nerve activity (MSNA) in
females and males during tonic muscle pain. There was no difference
between females (light gray) and males (dark gray) in the propensity to show
an increase or decrease in MSNA, and no differences in the magnitudes of the
peak changes during muscle pain.
vs. 20.2 ± 1.5 bursts/min; p = 0.19, unpaired Mann-
Whitney test), and no significant differences in any of the
other baseline cardiovascular parameters (Table 2). The only
statistically significant differences between males and females
were in BMI and muscle mass, both of which were significantly
higher in the males (p = 0.05 and p < 0.0001, respectively),
and age (p < 0.01)—on average, the females were one year
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TABLE 2 | Age, body-mass index (BMI), total muscle mass, MSNA
frequency (normalized to baseline), systolic arterial pressure (SAP),
diastolic arterial pressure (DAP), mean arterial pressure (MAP), heart rate
(HR) and specific components of heart rate variability (HRV; see Methods)
at baseline, divided by sex.
Females Males P-value
Number of subjects 25 25
Age (years) 22.8± 0.8 21.8± 1.5 <0.01
Height (cm) 164.0± 1.1 175.9± 1.7 <0.0001
Weight (kg) 61.5± 2.7 72.6± 2.2 <0.02
BMI (kg/m2) 22.9± 1.0 23.4± 0.5 0.05
Muscle mass (kg) 43.3± 0.8 57.8± 2.1 <0.0001
Pain rating (/10) 4.9± 0.2 4.9± 0.2 0.87
MSNA (bursts/min) 18.8± 1.5 20.2± 1.5 0.19
SAP (mmHg) 131.7± 6.3 133.3± 3.3 0.96
DAP (mmHg) 72.7± 5.4 72.7± 3.9 0.69
MAP (mmHg) 89.5± 5.5 86.6± 3.3 0.96
HR (beats/min) 75.0± 1.9 72.3± 1.9 0.32
LF HRV (nu) 61.7± 3.5 57.4± 3.2 0.21
HF HRV (nu) 33.8± 3.2 37.2± 3.0 0.16
LF/HF HRV 2.2± 0.3 1.8± 0.3 0.15
RMSSD HRV (ms) 39.0± 3.9 41.9± 4.5 0.64
Non-paired tests for all parameters; nu, normalized units.
older, though this is of no consequence because ages were not
significantly different in the increasing and decreasing groups (cf
Table 1).
DISCUSSION
This study extends the recent work conducted in our laboratory
on the effects of experimental muscle pain on the sympathetic
nervous system (Burton et al., 2008, 2009a,b; Fazalbhoy et al.,
2012, 2014; Hall et al., 2012). In our first study of 12 subjects
we found that tonic muscle pain, produced by intramuscular
infusion of hypertonic saline for 45min created divergent
changes in muscle sympathetic outflow: one group (n = 7)
showing an increase in MSNA and another (n = 5) showing a
decrease (Fazalbhoy et al., 2012). In a second study of 15 subjects,
we had reported that 11 subjects showed consistent increases
(n = 5) or decreases (n = 6) in MSNA when assessed on two
occasions at least 2 weeks apart (Fazalbhoy et al., 2014). Here we
have confirmed the findings of divergent sympathetic responses
to long-lasting muscle pain, but with a much larger sample size
(n = 50): one group of people (n = 24) showed an increase in
MSNA and another group (n = 26) showed a decrease.
Baseline Physiological Parameters
The findings of the current study suggest that the cardiovascular
responses to long-lasting muscle pain are not determined by
our measured baseline physiological levels; both the direction of
the response and the magnitude of change were independent of
baseline MSNA, heart rate, blood pressure, heart rate variability,
as well as age, sex, and BMI. This is consistent with studies
showing comparable control and sensitivity of the sympathetic
baroreflex in young men and young women (Tank et al., 2005;
Studinger et al., 2009; Hart et al., 2011). Whether, these findings
remain with increasing age is beyond the scope of this study.
However, it would be interesting to know whether the pattern of
response remains unchanged with age.
In this larger sample of subjects we found no correlation
between MSNA and heart rate, unlike the parallel changes
observed in the smaller data sets reported previously (Fazalbhoy
et al., 2012, 2014). Because of the dual innervation of the heart,
it may well be that the increase in sympathetic outflow to the
vascular bed in muscle is matched by a parallel increase in
cardiac sympathetic drive, which would increase heart rate, but
that a competing parasympathetic influence via the vagus nerve
counteracts this.
MSNA and Blood Pressure
Although, there was no difference in the changes in heart rate
and the change in MSNA between the two groups, in the group
of subjects in whom MSNA increased during tonic muscle pain
blood pressure was significantly higher than in the group in
whomMSNA decreased. This suggests that the increase inMSNA
was driving the increase in blood pressure, as an increase in
blood pressure should, via the baroreflex, lead to a fall in MSNA.
Indeed, the latter mechanism may explain why in some subjects
MSNA fell despite an increase in blood pressure: in these cases,
it would appear that the increase in blood pressure was causing a
baroreflex-mediated reduction inMSNA, while in other instances
a reduction in both blood pressure and MSNA could be the
result of a nociceptor-driven withdrawal of MSNA. However,
for those subjects in whom both MSNA and blood pressure
increased during tonic muscle pain, we would like to suggest that
nociceptor-driven increases in blood pressure could potentially
be a risk factor for the development of clinically significant high
blood pressure in the future, given that some individuals with
chronic pain go on to develop hypertension. Indeed, patients with
post-surgical chronic pain have nearly twice the prevalence of
clinical hypertension than medical patients without pain (Bruehl
et al., 2005). Accordingly, we could postulate that a person who
consistently exhibited increases in MSNA, blood pressure, and
heart rate during experimental muscle pain may—if he or she
developed chronic pain from an injury in the future—go on to
develop hypertension.
Heart Rate Variability
Heart rate variability is widely reported to reflect the degree
of sympathetic and parasympathetic control over the heart.
The LF band is proposed to represent (primarily) sympathetic
cardiac activation (Malliani et al., 1991), while the HF band is
proposed to reflect vagal cardiac control (Bernston et al., 1997).
Subsequently, the LF/HF ratio has been suggested as an index
of the sympathovagal balance (Cohen et al., 2000; Martinez-
Lavin, 2004; Staud, 2008; Reyes del Paso et al., 2011). The
value of HRV in distinguishing between cardiac sympathetic
and parasympathetic outflow is debatable (Goldstein et al.,
2011). However, that there was no difference between any HRV
parameters at either baseline or during tonic pain indicates that
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HRV is not related to whatever is responsible for the divergent
sympathetic responses to muscle pain seen in this study.
Limitations
The intramuscular infusion of hypertonic saline occurred at a
time unknown to the subject, who was asked to continuously
report the development of pain, as a rating out of 10, via the
linear potentiometer provided. Infusion rates were titrated—by
increasing or decreasing the rate of infusion in increments of
0.02ml/min—to maintain a constant level of pain. Although
we did not routinely record either the rate of infusion, or the
total volume infused, in each subject, we never exceeded 20ml
(as noted in Methods we used two syringes of 10ml each).
Nevertheless, there were no differences in total muscle mass in
the group in whom MSNA increased and the group in whom
MSNA decreased and, given that the infusion caused a notable
distension of the muscle belly in both groups, it is reasonable to
assume that there any changes in plasma osmolality were limited
to the muscle compartment and that comparable depolarization
of small-diameter axons by the hypertonic saline occurred in the
two groups. In other words, the noxious sensory input was the
same in the two groups, as reflected in the fact that there were
no significant differences in mean pain ratings between the two
groups. The same was true when we separated the cohort into
males and females: the only significant differences here being
the higher BMI and lower total muscle mass in the females,
both of which are expected. Of course, one could argue that the
intramuscular infusion of hypertonic saline would have a greater
effect in a smaller muscle (in the females), but in our experience
we see no differences in mean pain ratings in small muscles (e.g.,
intrinsic muscles of the hand) and large muscles (e.g., flexor carpi
radialis, deltoid, tibialis anterior), and pain ratings were the same
in males and females.
Implications
We have shown, in a large sample of subjects (n = 50), that
the baseline physiological parameters measured here do not
predict whether an individual exhibits an increase or decrease
in MSNA during long-lasting muscle pain. Furthermore, sex
appears to play no role in determining the direction of
response to muscle pain. Unlike the short-lasting pain we
had previously induced by bolus injections (Burton et al.,
2009a,b), we believe the physiological responses to tonic pain
will more closely replicate episodes during which chronic pain
patients are suffering and coping with their pain. Persistent
deep pain in experimental animals has been shown to provoke
a passive coping response—i.e., conservation/withdrawal (Keay
and Bandler, 2002). Of course, while tonic muscle pain lasting
only 20min has been used as amodel for chronic musculoskeletal
pain (Capra and Ro, 2004), we should stress that this only
reflects continuous nociceptive pain and not the neuropathic
pain typically associated with chronic pain. Nevertheless, this
method of inducing pain offers the advantage of allowing a
controlled investigation into how pain may modulate MSNA,
blood pressure, and heart rate. Conversely—assuming everything
else is equal—one would need to know the level of MSNA
in a person prior to the development of chronic pain in
order to interpret any changes in muscle sympathetic outflow.
Microelectrode recordings of sympathetic nerve traffic in human
subjects have found no differences in sympathetic outflow to
a painful limb compared to the contralateral non-painful limb
in patients with complex regional pain syndrome, suspected to
be sympathetically maintained because of the marked cutaneous
vasoconstriction (Casale and Elam, 1992). In order to understand
the neurophysiological basis of the divergent sympathetic
responses to experimental muscle pain, further investigations
are needed, as the current results fail to demonstrate that
baseline physiological parameters, BMI or sex, play a role in the
cardiovascular responses to long-lasting muscle pain in humans.
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